Anti-CEBP Beta antibody [E299] - C-terminal (Ab32358)
TCF5, PP9092, CEBPB, CCAAT/enhancer-binding protein beta, C/EBP beta, Liver activator protein, Liver-enriched inhibitory protein, Nuclear factor NF-IL6, Transcription factor 5, LAP, LIP, TCF-5
详细信息
特异性
This antibody is specific for the three CEBPB isoforms (LAP*, LAP and LIP). According to BLAST analysis, the antibody could cross-react with CEBP epsilon (32, 27 and 14kDa, 82% homology) and CEBP alpha (42kDa, 30kDa, 73% homology) in human, mouse and rat. Please be aware that this has not been confirmed experimentally. However, this could explain the background that could possibly be obtained in WB with this antibody. Please contact our Scientific Support if you have any questions.
背景信息
What is this antibody validated in? Anti-CEBP Beta antibody [E299] - C-terminal (ab32358) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of CEBP Beta? Anti-CEBP Beta [E299] - C-terminal (ab32358) specifically detects a band for CEBP Beta (UniProt: P21272) at a molecular weight of 36kDa. Trusted by the scientific community Anti-CEBP Beta [E299] - C-terminal (ab32358) was first used in a scientific publication in 2006 and has been cited over 100 times in peer-reviewed journals. Reviewed by scientists Anti-CEBP Beta [E299] - C-terminal (ab32358) has over 5 independent reviews from customers. Specificity confirmed The specificity of Anti-CEBP Beta antibody [E299] - C-terminal (ab32358) has been confirmed by Western blot testing in CEBPB Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [E299] also available for your convenience: ab32358, Carrier free - ab220813, Alexa Fluor ® 488 - ab237414, Alexa Fluor ® 647 - ab237415 Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (105)
CEBPB-high dormant tumor cells drive immune evasion via S100A8 orchestrated tumor-associated macrophages reprogramming
CEBPB高表达的休眠肿瘤细胞通过S100A8调控的肿瘤相关巨噬细胞重编程驱动免疫逃逸
A fibroblast-like endothelial cell state promotes atherosclerosis via C/EBPβ-activated TGF-β signaling.
成纤维细胞样内皮细胞状态通过 C/EBPβ 激活的 TGF-β 信号传导促进动脉粥样硬化。
INHBA, regulated by C/EBPβ, induces M2 macrophage polarization to promote tumor metastasis and growth via activating the PI3K/AKT pathway in gastric cancer.
INHBA 受 C/EBPβ 调控,诱导 M2 巨噬细胞极化,通过激活胃癌中的 PI3K/AKT 通路促进肿瘤转移和生长。
Dual role of icaritin in attenuating allograft rejection and exerting antitumor effects in mice.
淫羊藿苷在减轻同种异体移植排斥反应和发挥抗肿瘤作用方面的双重作用。
Molecular mechanism of berberine in ameliorating leptin resistance and mitochondrial dysfunction through the TRIB1-C/EBPα axis in obesity.
小檗碱通过 TRIB1-C/EBPα 轴改善肥胖症中瘦素抵抗和线粒体功能障碍的分子机制。
C/EBPβ activation in vascular smooth muscle cells promotes hyperlipidemia-induced phenotypic transition and arterial stiffness
血管平滑肌细胞中C/EBPβ的激活促进高脂血症诱导的表型转变和动脉僵硬
Dual mechanism of autophagy gene repression by PHF23 and therapeutic potential of its inhibition in protein aggregation disorders.
PHF23对自噬基因的双重抑制机制及其在蛋白质聚集疾病中的抑制治疗潜力。
CCAAT/enhancer binding protein beta (C/EBPβ) regulates the formation of the ovarian reserve
CCAAT/增强子结合蛋白β (C/EBPβ) 调节卵巢储备的形成
N6-methyladenosine RNA modification regulates microglial phagocytosis in the APP/PS1 mouse model of Alzheimer's disease.
N6-甲基腺苷RNA修饰调节APP/PS1阿尔茨海默病小鼠模型中的小胶质细胞吞噬作用。
The m6A demethylase FTO promotes C/EBPβ-LIP translation to perform oncogenic functions in breast cancer cells.
m6A 去甲基酶 FTO 促进 C/EBPβ-LIP 翻译,从而在乳腺癌细胞中发挥致癌功能
- 1
- 2
- 3
- 4
- 5
- 6
- 11